Skip to content
conflictLOW2026-04-30 15:13 UTC

XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue rise

Plus, news about PCI Pharma: 🏭 XTL Bio steps into psychedelics: XTL Biopharmaceuticals is acquiring 100% of the outstanding shares of psychedelic-focused biotech Psyga Bio. XTL will gain Psyga’s manufacturing facility ...

ORIGINAL SOURCE →via Endpoint News
ADVERTISEMENT
⚡ STAY AHEAD

Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.

GET THE SUNDAY BRIEFING →

RELATED · conflict